Voleon Capital Management »

Entrada Therapeutics shares owned by Voleon Capital Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Voleon Capital Management from 13F filings

Historical chart of Voleon Capital Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Voleon Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Voleon Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $186k 25k 7.36

More positions owned by Voleon Capital Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Micron Technology (MU)
JPMorgan Chase & Co. (JPM)
Broadcom (AVGO)
Mastercard Incorporated Cl A (MA)
Sandisk Corp (SNDK)
Eli Lilly & Co. (LLY)
Intel Corporation (INTC)
Astera Labs (ALAB)

View all positions for Voleon Capital Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics